Kerwin Shannon

Head and Neck Surgeon / Surgical Oncologist

Chris O'Brien Lifehouse

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kerwin Shannon is a Head and Neck Surgeon and Surgical Oncologist at Chris O’Brien Lifehouse in Australia. His research focuses on melanoma treatment, including neoadjuvant therapies, sentinel node positivity, and the management of angiosarcoma. He has published extensively on topics related to surgical outcomes and cost-effectiveness in specialty care, particularly in rural settings.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Rebecca Venchiarutti

Head and Neck Research Fellow

Chris O'Brien Lifehouse

AUSTRALIA

View details

Rebecca Read

The Australian National University

AUSTRALIA

View details

Madeleine Cornelia Strach

Clinical Senior Lecturer

University of Sydney

AUSTRALIA

View details

Serigne N. Lô

AUSTRALIA

View details

Sydney Ch'ng

AUSTRALIA

View details

John Thompson

Emeritus Professor of Melanoma & Surgical Oncology

University of Sydney

AUSTRALIA

View details

Elizabeth Burton

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kerwin Shannon

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node–positivity in melanoma patients

Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial

Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection

Travel‐associated cost savings to patients and the health system through provision of specialist head and neck surgery outreach clinics in rural New South Wales, Australia

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).

Outcomes after definitive treatment for head and neck angiosarcoma

Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases

Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients

Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread

Collaborators (7)

Rebecca Venchiarutti

Rebecca Read

Madeleine Cornelia Strach

Serigne N. Lô

Sydney Ch'ng

John Thompson

Elizabeth Burton

Make your next move.